A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL
Clinical trial NCT05883085 · UNKNOWN
Trial details
- NCT number
- NCT05883085
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.